Quantcast

Latest bladder cancer Stories

2014-09-15 23:11:36

A collaborative study between researchers at the University of Colorado Cancer Center and the National Cancer Institute (NCI) published today in the journal Clinical Cancer Research takes an important step toward answering the question: which altered genes are most to blame for bladder cancer? AURORA, Colo. (PRWEB) September 15, 2014 The story of cancer care seems so simple: find the mutated gene that causes cancer and turn it off or fix it. But rarely does a single gene cause cancer....

2014-09-08 23:02:32

Drug makers Takeda and Eli Lilly lost a bid to have the Actos trial thrown out. The Jury has been deemed to have appropriately considered the case and the settlement amounts have been deemed sound. Port Washington, NY (PRWEB) September 08, 2014 Parker Waichman LLP, a national law firm that has long been dedicated to protecting the rights of victims who have been injured by medications reports that Takeda Pharmaceuticals Co. indicated that a United States district court mandated the drug...

2014-09-03 08:34:30

DUNEDIN, New Zealand and HERSHEY, Pa., Sept. 3, 2014 /PRNewswire/ -- Pacific Edge Ltd, a cancer diagnostics company, has signed an agreement with Southern California Permanente Medical Group (SCPMG) to research its User Program to evaluate its bladder cancer technology Cxbladder within the clinical settings of Kaiser Permanente's health care network. http://photos.prnewswire.com/prnvar/20131015/MM98246LOGO The Kaiser Permanente User Program research project is planned to recruit...

2014-08-31 23:01:38

The Firm is evaluating Actos lawsuits on behalf of individuals who developed bladder cancer, allegedly due to long-term use of the Type 2 diabetes drug. New Yor, New York (PRWEB) August 31, 2014 The federal judge overseeing thousands of Actos bladder cancer lawsuits (http://www.theactoslawsuitcenter.com/) in the U.S. District Court, Western District of Louisiana has refused to overturn a $9 billion verdict rendered in the proceeding’s first bellwether trial, Bernstein Liebhard LLP...

2014-08-30 23:00:40

In light of the latest development in Actos litigation, The Law Office of Melinda J. Helbock A.P.C. announces that it continues to investigate potential lawsuits on behalf of Actos users who have been diagnosed with bladder cancer. San Diego, CA (PRWEB) August 30, 2014 According to Bloomberg, U.S. District Judge Rebecca Doherty upheld a decision that requires Takeda Pharmaceutical Co. and Eli Lilly & Co. to pay $9 billion in punitive damages for claims that the drugmakers concealed...

2014-08-28 12:30:33

No overall statistically significant increased risk of bladder cancer in patients ever exposed to pioglitazone in a completed 10-year epidemiological study OSAKA, Japan, Aug. 28, 2014 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") today announced the completion of the post-marketing commitment and submissions of data from a 10-year epidemiology study to regulatory authorities including the United States (U.S.) Food and Drug Administration (FDA), the European Medicines Agency...

2014-08-11 08:28:56

SAN DIEGO, Aug. 11, 2014 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX) today announced that the U.S. FDA has granted Orphan Drug Designation to mocetinostat, a spectrum selective HDAC inhibitor, for diffuse large B-cell lymphoma (DLBCL). In June, mocetinostat was granted Orphan Drug Designation as a treatment for myelodysplastic syndrome (MDS). Orphan drug designation is also being sought for bladder cancer patients with specific genetic alterations. Mocetinostat is being...

2014-08-11 04:22:07

MT Services LLC informs plaintiffs on ongoing cases with Takeda Pharmaceutical, manufacturer of Actos (Pioglitazone hydrochloride) diabetes drug, seeking post-trial motions to lower $9Bil. verdict. NEW ORLEANS, Aug. 11 2014 /PRNewswire/ -- MT Services LLC, The Lawsuit Settlement News Reporting Company, reported today that there are still claims being filed, lawsuits being heard, and possible settlements discussions in the works, for patients of the reputed bad pharmaceutical drug...

cancer classification system
2014-08-10 05:02:57

Rayshell Clapper for redOrbit.com - Your Universe Online Researchers released some pretty incredible findings last week about cancer. In a multiple institute study including researchers and authors from the University of California at Santa Cruz (UCSC), the Buck Institute for Research on Aging, the University of California at San Francisco (UCSF), the University of North Carolina, Chapel Hill (UNC), and the Broad Institute of Harvard and MIT looked closely at how cancers are classified....

2014-08-04 23:05:10

Takeda Pharmaceuticals Co. and Eli Lilly & Co. moving for new trial Port Washington, New York (PRWEB) August 04, 2014 Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs and medical devices, reports that the plaintiffs who recently won a $9 billion punitive damages award in the first federal bellwether trial involving Takeda Pharmaceutical’s diabetes medication, Actos, say the verdict should be upheld. According to the...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related